Biodegradable Fiducial Markers for Bimodal Near-Infrared Fluorescence- and X-ray-Based Imaging

No prior work had resolved the challenge of creating markers visible through both X-ray and fluorescence imaging. Current clinical options often lack the versatility required for combined surgical and radiation guidance. That uncertainty drove the need for new implantable devices. Prior research has shown that biodegradable materials offer significant advantages for long-term patient safety. However, integrating dual-modality contrast agents into these structures remains difficult. This gap motivated the development of specialized composite materials. Scientists have previously explored various polymers for medical implants. Yet, few studies have successfully combined radiopaque and fluorescent properties within a single degradable unit.

The aim of this research was to evaluate novel implantable, biodegradable markers for bimodal imaging. The authors sought to combine near-infrared fluorescence and X-ray capabilities into a single device. This study addressed the need for markers that assist in both surgical tumor removal and subsequent radiation therapy. The researchers focused on developing a core-shell structure using specific polymers. They investigated the use of approved contrast agents as fillers within these structures. A key motivation was to determine if hydroxyapatite could tailor the stability of the core materials. The team also intended to verify the safety and tissue compatibility of these new composites. Ultimately, the work aimed to provide a solution for more precise image-guided cancer treatments.

Review Approach involved evaluating the performance of newly engineered composite structures. The team fabricated core-shell devices using specific polymers and contrast agents. They performed in situ assessments using porcine tissue samples to verify visibility. In vivo experiments were conducted using a rat model to monitor biological responses. The researchers analyzed the stability of the contrasting properties under various conditions. They compared the effects of adding hydroxyapatite to different core fillers. Material characterization techniques were employed to explain observed differences in stability. Finally, the study assessed tissue compatibility to ensure safety during and after radiation exposure.

Key Findings From the Literature indicate that the developed markers provide clear visibility for both fluorescence and X-ray imaging. The addition of hydroxyapatite improved the initial radiopacity of the devices. In iohexol-containing markers, the presence of hydroxyapatite slightly reduced the stability of the contrast properties. Conversely, changes were less pronounced in markers containing barium sulfate. Tissue response around the composite cores was comparable to that of pristine polymeric controls. The markers did not cause serious adverse effects on surrounding tissues, even after radiation exposure. The study confirms that these materials effectively support image-guided surgery and radiotherapy. These results demonstrate the potential of the composite design for clinical use.

The authors propose that these composite markers offer a viable solution for dual-modality medical imaging. Their findings suggest that the materials provide clear visibility for both surgical and radiation procedures. The researchers note that the tissue response remains safe and comparable to standard polymeric implants. They observe that hydroxyapatite influences the stability of the contrast agents differently depending on the filler used. The study indicates that barium sulfate-based cores show more consistent behavior than those containing iohexol. The team concludes that these devices do not trigger significant adverse biological effects during testing. They emphasize that the technology holds high potential for clinical applications in oncology. Finally, the work provides a foundation for future developments in biodegradable imaging tools.